Prashant N Chhajed
Overview
Explore the profile of Prashant N Chhajed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
855
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhar R, Talwar D, Christopher D, Dumra H, Koul P, Chhajed P, et al.
J Asthma
. 2024 May;
61(10):1152-1164.
PMID: 38767570
Objective: In this document, 9 Indian experts have evaluated the factors specific to LMICs when it came to Severe Asthma (SA) diagnosis, evaluation, biologic selection, non-biologic treatment options, and follow-up....
2.
Christopher D, Gupta R, Thangakunam B, Daniel J, Jindal S, Kant S, et al.
Lung India
. 2024 May;
41(3):230-248.
PMID: 38704658
Pleural effusion is a common problem in our country, and most of these patients need invasive tests as they can't be evaluated by blood tests alone. The simplest of them...
3.
Kleinsorge L, Pasha Z, Boesing M, Abu Hussein N, Bridevaux P, Chhajed P, et al.
Swiss Med Wkly
. 2023 Nov;
153(11):40114.
PMID: 37955986
Background: Chronic obstructive pulmonary disease (COPD) is a widespread chronic disease characterised by irreversible airway obstruction [1]. Features of clinical practice and healthcare systems for COPD patients can vary widely,...
4.
Abu Hussein N, Giezendanner S, Urwyler P, Bridevaux P, Chhajed P, Geiser T, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892832
Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from acute exacerbations. Our objective was to describe recurrent exacerbations in a GP-based Swiss COPD cohort and develop a statistical...
5.
Mandovra N, Vaidya P, Shah R, Nighojkar A, Chavhan V, Lohiya A, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892651
The aim of the study was to examine the best-tolerated dose of pirfenidone, the adverse effects profile, and potential factors other than drug dose influencing the tolerability of pirfenidone in...
6.
Muthu V, Agarwal R, Patel A, Kathirvel S, Abraham O, Aggarwal A, et al.
Lancet Infect Dis
. 2022 Apr;
22(9):e240-e253.
PMID: 35390293
COVID-19-associated pulmonary mucormycosis (CAPM) remains an underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus statement for the diagnosis and management of CAPM. We selected 26 experts...
7.
Salvi S, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed P, et al.
Lung India
. 2022 Mar;
39(2):177-186.
PMID: 35259802
No abstract available.
8.
Tschacher A, Cadus C, Schildge S, Diedrich J, Chhajed P, Leuppi-Taegtmeyer A, et al.
Curr Med Res Opin
. 2021 Aug;
37(11):2019-2033.
PMID: 34433362
Objective: The aims of the survey were to assess first experiences of Swiss COPD patients switching from the disposable to the new reusable Respimat inhaler, and to evaluate physicians´ and...
9.
Hasan A, Mukherjee P, Chhowala S, Lopez M, Chhajed P
Lung India
. 2021 Jul;
38(4):350-358.
PMID: 34259174
Asthma and chronic obstructive pulmonary disease (COPD) are common chronic respiratory diseases characterized by an inflammatory process that extends from the central to peripheral airways. Conventional pressurized metered-dose inhalers and...
10.
Marmy J, Diedrich J, Cadus C, Grendelmeier P, Tschacher A, Dieterle T, et al.
COPD
. 2020 Dec;
18(1):9-15.
PMID: 33342309
Significant variability in adherence to COPD management recommendations has been reported. We aimed to evaluate real-life COPD pharmacotherapy prescribing patterns and adherence to the 2017 Global Initiative for Chronic Obstructive...